All In MedTech

FDA Clearance Tracker · P020025

EP TECHNOLOGIES EPT-1000 XP RF ABLATION SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Aug 25, 2003 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Aug 25, 2003

Approved

Time to decision

427 days

Received Jun 24, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P020025
Device name
EP TECHNOLOGIES EPT-1000 XP RF ABLATION SYSTEM
Applicant location
St Paul, MN
Received
Jun 24, 2002
Decided
Aug 25, 2003
Decision
Approved
Supplements
141 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code OAD

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE EP TECHNOLOGIES EPT-1000 XP RF ABLATION SYSTEM. THE BLAZER II XP CARDIAC ABLATION CATHETER IS INDICATED FOR USE WITH THE EPT-1000 XP CARDIAC ABLATION CONTROLLER AND ACCESSORIES FOR THE TREATMENT OF SUSTAINED OR RECURRENT TYPE I ATRIAL FLUTTER IN PATIENTS AGE 18 OR OLDER. THE EPT-1000 XP CARDIAC ABLATION CONTROLLER AND ACCESSORIES ARE INDICATED FOR USE IN CONJUNCTION WITH STANDARD AND HIGH POWER CATHETERS FOR CARDIAC ABLATION PROCEDURES.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code OAD. The earliest in FDA's data is P010068, decided Sep 27, 2002.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Boston Scientific

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.